Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma
for
Pancreatic Cancer
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 18+
Code: NCT06141031
Phase1, Recruiting
Resection/Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma
for
Adenocarcinoma of the Pancreas
Location: San Antonio TX
Sponsor: The University of Texas Health Science Center at San Antonio
Sex: All
Age: 0+
Code: NCT07340151
Recruiting
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
for
Solid Tumors
Location: Boston MA, Lake Success NY, The Bronx NY, New York NY,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07522073
Phase3, Recruiting
Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II)
for
Pancreatic Cancer
Location: San Francisco CA
Sponsor: SONIRE Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT07033689
Early_phase1, Recruiting
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
for
Cancer Weight Loss
Location: New York NY, Charlottesville VA, Durham NC,
Sponsor: Endevica Bio
Sex: All
Age: 18+
Code: NCT06937177
Phase2, Recruiting
Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
for
Adenocarcinoma, Carcinoma, Pancreatic Ductal
Location: Shirley NY, Albany NY, East Brunswick NJ, Morristown NJ,